{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "7798779",
  "DateCompleted": {
    "Year": "1995",
    "Month": "01",
    "Day": "20"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0024-6921",
      "JournalIssue": {
        "Volume": "146",
        "Issue": "10",
        "PubDate": {
          "Year": "1994",
          "Month": "Oct"
        }
      },
      "Title": "The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society",
      "ISOAbbreviation": "J La State Med Soc"
    },
    "ArticleTitle": "Ceftazidime as monotherapy for fever and neutropenia: experience in a community hospital.",
    "Pagination": {
      "StartPage": "448",
      "EndPage": "452",
      "MedlinePgn": "448-52"
    },
    "Abstract": {
      "AbstractText": [
        "Fever and neutropenia is occurring in a wider variety of clinical settings, and the proper antibiotic therapy for its treatment is an area of debate. Our study is a retrospective analysis of the experience of the Oncology Division of the Medical Center of Baton Rouge, which used ceftazidime as monotherapy in the empiric treatment of fever and neutropenia. A total of 53 episodes in 38 patients were studied. Using ceftazidime as monotherapy in our study population was associated with an 8% mortality rate, indicating that monotherapy is a viable option for the treatment of fever and neutropenia."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dept of Internal Medicine, Ochsner Clinic, New Orleans, La 70121."
          }
        ],
        "LastName": "Bizette",
        "ForeName": "G A",
        "Initials": "GA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Brooks",
        "ForeName": "B J",
        "Initials": "BJ",
        "Suffix": "Jr"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Alvarez",
        "ForeName": "S",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J La State Med Soc",
    "NlmUniqueID": "7505618",
    "ISSNLinking": "0024-6921"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "9M416Z9QNR",
      "NameOfSubstance": "Ceftazidime"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Ceftazidime"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gram-Negative Bacteria"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Neutropenia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Retrospective Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ]
}